Myokardia, Inc.
SEC CIK 1552451 · MYOK · last insider filing 2020-11-19
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cranston Mary B | Director | filed 2016 - 2020 |
| Yarno Wendy L | Director | filed 2017 - 2020 |
| Perry Mark L | Director | filed 2015 - 2020 |
| Popovits Kimberly J | Director | filed 2017 - 2020 |
| Meeker David P | Director | filed 2017 - 2020 |
| Gianakakos Anastasios | Director · President and CEO | filed 2015 - 2020 |
| Agarwal Sunil | Director | filed 2016 - 2020 |
| Starr Kevin P | Director | filed 2015 - 2018 |
| Topol Eric | Director | filed 2015 - 2017 |
| Homcy Charles J | Director | filed 2015 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mcdowell Robert Scott | Senior VP, Drug Discovery | filed 2015 - 2020 |
| Harris Taylor C. | Chief Financial Officer | filed 2018 - 2020 |
| Bauer Jake | See Remarks | filed 2015 - 2020 |
| Fairey William | See Remarks | filed 2019 - 2020 |
| Waynick Denelle J | General Counsel | filed 2020 - 2020 |
| Ladd Cynthia J | General Counsel | filed 2018 - 2020 |
| Lee June | See Remarks | filed 2017 - 2019 |
| Lambing Joseph | See Remarks | filed 2015 - 2019 |
| Semigran Marc | Chief Medical Officer | filed 2016 - 2019 |
| Chan Steven | See Remarks | filed 2015 - 2017 |
| Fox Jonathan C | Chief Medical Officer | filed 2015 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.